Leogenic Healthcare Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Vogblu Trio 2mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults.
Tablet
Vogblu Trio 2mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Vogblu Trio 2mg/500mg/0.2mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Vogblu Trio 2mg/500mg/0.2mg Tablet.
Vogblu Trio 2mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Vogblu Trio 2mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Vogblu Trio 2mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Vogblu Trio 2mg/500mg/0.2mg Tablet contains a combination of Glimepiride, Metformin and Voglibose. It's used for the treatment of type 2 diabetes mellitus (DM). This medicine improves blood glucose levels in adults when taken alongside proper diet and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin works by lowering glucose production in the liver and enhancing insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meal) glucose levels.
Side effects associated with Vogblu Trio 2mg/500mg/0.2mg Tablet may include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Avoid using this medicine if you have known allergies to any of its components or excipients. It is also not recommended for individuals with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations or underlying metabolic acidosis including diabetic ketoacidosis.
No, combining alcohol with Vogblu Trio 2mg/500mg/0.2mg Tablet is not advisable as it may exacerbate hypoglycemia and increase the risk of lactic acidosis.
Yes, Vogblu Trio 2mg/500mg/0.2mg Tablet can cause hypoglycemia (low blood sugar levels). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. It is more likely to occur when missing meals, consuming alcohol, over-exercising, or taking other antidiabetic medications simultaneously. Regular monitoring of blood sugar levels is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Store this medicine in its original packaging, tightly sealed. Follow the instructions on the label or pack. Dispose of unused medication responsibly; it should not be consumed by pets, children, or other individuals.